Abstract:Mutations in the gene FUSED IN SARCOMA (FUS) are among the most frequently occurring genetic forms of amyotrophic lateral sclerosis (ALS). Early pathogenesis of FUS-ALS involves impaired DNA damage response and axonal degeneration. However, it is still poorly understood how these gene mutations lead to selective spinal motor neuron (MN) degeneration and how nuclear and axonal phenotypes are linked. To specifically address this, we applied a compartment specific RNA-sequencing approach using microfluidic chambers to generate axonal as well as somatodendritic compartment-specific profiles from isogenic induced pluripotent stem cells (iPSCs)-derived MNs. We demonstrate high purity of axonal and soma fractions and show that the axonal transcriptome is unique and distinct from that of somas including significantly fewer number of transcripts. Functional enrichment analysis revealed that differentially expressed genes (DEGs) in axons were mainly enriched in key pathways like RNA metabolism and DNA damage, complementing our knowledge of early phenotypes in ALS pathogenesis and known functions of FUS. In addition, we demonstrate a strong enrichment for cell cycle associated genes including significant upregulation of polo-like kinase 1 (PLK1) in FUSP525L mutant MNs. PLK1 was increased upon DNA damage induction and PLK1 inhibition further increased the number of DNA damage foci in etoposide-treated cells, an effect that was diminished in case of FUS mutant MNs. In contrast, inhibition of PLK1 increased late apoptotic or necrosis-induced neuronal cell death in mutant neurons. Taken together, our findings provide insights into compartment-specific transcriptomics in human FUS-ALS MNs and we propose that specific upregulation of PLK1 might represent an early event in the pathogenesis of ALS, possibly modulating DNA damage response and other associated pathways.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the specific mechanism of FUS gene mutations (especially the FUS P525L mutation) in amyotrophic lateral sclerosis (ALS), especially how this mutation leads to the selective degeneration of spinal motor neurons and the connection between their nuclear and axonal phenotypes. Specifically, the study aims to reveal the molecular changes that occur during the early ALS pathological process by analyzing the axon - specific transcriptome of motor neurons derived from induced pluripotent stem cells (iPSCs). ### Research Background - **FUS Gene and ALS**: Mutations in the FUS gene are one of the most common genetic forms in familial ALS, especially more prevalent in younger patients. These mutations can lead to impaired DNA damage response and axonal degeneration. - **Cell Compartment Specificity**: The early pathological process of ALS involves changes in specific neuronal compartments (such as distal axons), and these changes can provide important clues for understanding the disease mechanism. - **Insufficiency of Existing Research**: Currently, less is known about how FUS mutations lead to the selective degeneration of spinal motor neurons and the relationship between nuclear and axonal phenotypes. ### Research Methods The researchers used microfluidic technology combined with RNA sequencing (RNA - seq) to culture motor neurons derived from iPSCs carrying the FUS P525L mutation in vitro and analyzed the transcriptomes of their somatodendritic (SD) and axonal compartments respectively. ### Main Findings 1. **Uniqueness of Axon Transcriptome**: - The number of transcripts in axons is significantly less than that in the somatodendritic compartment. - Differentially expressed genes (DEGs) are mainly enriched in key pathways such as RNA metabolism and DNA damage repair. 2. **Up - regulation of PLK1**: - In motor neurons with the FUS P525L mutation, cell - cycle - related genes are significantly up - regulated, especially PLK1 (polo - like kinase 1). - The up - regulation of PLK1 is related to the enhanced DNA damage response, and inhibiting PLK1 will increase the number of DNA damage foci. 3. **Functional Consequences**: - Inhibiting PLK1 increases neuronal death caused by late - stage apoptosis or necrosis, especially in mutant neurons. - It is proposed that the specific up - regulation of PLK1 may be an important event in the early pathological process of ALS and may regulate the DNA damage response and other related pathways. ### Conclusion This study, through detailed transcriptome analysis, has revealed the molecular changes in motor neuron axons with the FUS P525L mutation, especially the up - regulation of PLK1 and its impact on the DNA damage response. These findings provide a new perspective for further understanding the pathological mechanism of ALS and may provide potential targets for future treatment strategies. ### Formula Presentation When describing the DNA damage response, some of the involved formulas can be represented in Markdown format as follows: - The mathematical model of the DNA damage response can be represented as: \[ \text{DNA Damage Response} = f(\text{DNA damage level}, \text{repair efficiency}) \] where \( f \) is a function representing the relationship between the DNA damage level and the repair efficiency. - The up - regulation of PLK1 activity can be represented by the following formula: \[ \text{PLK1 Activity}_{\text{mutant}}=\alpha\cdot\text{PLK1 Activity}_{\text{wild - type}} \] where \( \alpha > 1 \), representing the multiple of increase in PLK1 activity in mutant neurons. It is hoped that this information will help you better understand the research content of this paper. If you have more questions, please feel free to ask.

Axonal transcriptome reveals upregulation of PLK1 as a protective mechanism in response to increased DNA damage in FUSP525L spinal motor neurons

FUS Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived hiPSCs and Aging Motoneurons

Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons

Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis

Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient.

Damaged DNA is an Early Event of Neurodegeneration in Induced Pluripotent Stem Cell-Derived Motoneurons with UBQLN2P497H Mutation

FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease

Single cell RNA sequencing in isogenic FUS and TARDBP mutant ALS lines reveals early mitochondrial dysfunction as a common pathway in motor neurons

Neuromuscular dysfunction in patient-derived FUS -ALS iPSC model via axonal downregulation of neuromuscular junction proteins

ALS-FUS mutation affects the activities of HuD/ELAVL4 and FMRP leading to axon phenotypes in motoneurons

Proteomics analysis of FUS mutant human motoneurons reveals altered regulation of cytoskeleton and other ALS-linked proteins via 3′UTR binding

Integrated temporal profiling of iPSCs-derived motor neurons from ALS patients carrying C9orf72, FUS, TARDBP, and SOD1 mutations

PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport

FUS Unveiled in Mitochondrial DNA Repair and Targeted Ligase-1 Expression Rescues Repair-Defects in FUS-Linked Neurodegeneration

The Fused in Sarcoma Protein Forms Cytoplasmic Aggregates in Motor Neurons Derived from Integration-Free Induced Pluripotent Stem Cells Generated from a Patient with Familial Amyotrophic Lateral Sclerosis Carrying the FUS-P525L Mutation

FUS-regulated RNA metabolism and DNA damage repair: Implications for amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis.

Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis

A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons

Synaptic accumulation of FUS triggers age-dependent misregulation of inhibitory synapses in ALS-FUS mice

Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal Development

Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs